{"id":"NCT00775645","sponsor":"SWOG Cancer Research Network","briefTitle":"S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo","officialTitle":"S0715: Randomized Placebo-Controlled Trial of Acetyl-L-Carnitine (ALC) for the Prevention of Taxane Induced Neuropathy Phase III","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-09","primaryCompletion":"2012-01","completion":"2013-06","firstPosted":"2008-10-20","resultsPosted":"2017-04-10","lastUpdate":"2017-08-14"},"enrollment":437,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Breast Cancer","Chemotherapeutic Agent Toxicity","Fatigue","Neuropathy","Neurotoxicity"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"acetyl-L-carnitine hydrochloride","otherNames":[]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Arm I","type":"EXPERIMENTAL"},{"label":"Arm II","type":"PLACEBO_COMPARATOR"}],"summary":"RATIONALE: Acetyl-L-carnitine may prevent or lessen neuropathy caused by chemotherapy. It is not yet known whether acetyl-L-carnitine is more effective than a placebo in preventing neuropathy caused by chemotherapy.\n\nPURPOSE: This randomized phase III trial is studying acetyl-L-carnitine to see how well it works compared with a placebo in preventing neuropathy in women with stage I, stage II, or stage III breast cancer undergoing chemotherapy.","primaryOutcome":{"measure":"12-week FACT-Taxane Neurotoxicity Model-adjusted Score in ALC and Placebo Groups","timeFrame":"12 weeks post-registration","effectByArm":[{"arm":"Arm I (Acetyl-L-carnitine Hydrochloride))","deltaMin":35.4,"sd":null},{"arm":"Arm II (Placebo)","deltaMin":36.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.17"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":295,"countries":["United States"]},"refs":{"pmids":["23733756"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":208},"commonTop":["Neuropathy: sensory","Nausea","Insomnia","Fatigue (asthenia, lethargy, malaise)","Hot flashes/flushes"]}}